SUNFLOWER(SZ:300111) Zhong Guo Ji Jin Bao·2025-09-21 12:28Core Viewpoint - Sunflower will resume trading on September 22, 2025, after a suspension for significant asset restructuring [2] Group 1: Company Restructuring - Sunflower plans to acquire 100% of Zhangzhou Xipu Materials Technology Co., Ltd. and 40% of Zhejiang Beid Pharmaceutical Co., Ltd. through a combination of issuing shares and cash payments [3] - The acquisition aims to enter the high-end semiconductor materials sector, creating a second growth curve for the company [5] Group 2: Financial Performance - Xipu Materials is projected to achieve revenues of 38.54 million yuan and 98.54 million yuan for 2023 and 2024, respectively, with net profits of 40,800 yuan and 13.77 million yuan [4] - Sunflower's net profit has shown a declining trend from 56 million yuan in 2020 to 7.83 million yuan in 2024 [8] - In the first half of 2025, Sunflower reported revenues of 144 million yuan, a year-on-year decrease of 8.33%, and a net profit of 1.16 million yuan, down 35.68% year-on-year [9] Group 3: Shareholder Activity - Morgan Stanley increased its holdings in Sunflower by 724,800 shares, bringing its total to 6.43 million shares, representing 0.5% of the company [6] - Major shareholders include Wu Jianlong with 28.79% and Zhejiang Yingcao Investment Co., Ltd. with 1.19% [7]